Agilent Technologies Inc. (A)
Aquatic Capital Management LLC Decreases Stake in Agilent Technologies, Inc. $A
Aquatic Capital Management LLC reduced its position in Agilent Technologies, Inc. (NYSE: A) by 43.6% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 53,601 shares of the medical research company's stock after selling 41,359 shares during the period. Aquatic Capital Management LLC's holdings in
Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More
Citi swept through its life science tools and diagnostics coverage on Wednesday, opening a 90-day upside catalyst watch on Agilent Technologies ( NYSE:A ) while trimming its price target on Icon PLC ( NASDAQ:ICLR ) following a turbulent earnings season for the sector.
Agilent to acquire Biocare Medical in $950 million all-cash deal
Life sciences firm Agilent Technologies said on Monday that it will acquire clinical pathology firm Biocare Medical in an all-cash deal valued at $950 million.
Investing in Agilent (A)? Don't Miss Assessing Its International Revenue Trends
Evaluate Agilent's (A) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Agilent Q1 Earnings Miss Estimates, Revenues Up Y/Y, Shares Fall
A posts Q1 revenue growth and beats sales estimates, but margin pressure and earnings miss send shares lower in pre-market trade.
Agilent Technologies, Inc. (A) Q1 2026 Earnings Call Transcript
Agilent Technologies, Inc. (A) Q1 2026 Earnings Call Transcript
Agilent (A) Reports Q1 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended January 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Agilent Technologies (A) Lags Q1 Earnings and Revenue Estimates
Agilent Technologies (A) came out with quarterly earnings of $1.36 per share, missing the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $1.31 per share a year ago.
Stay Ahead of the Game With Agilent (A) Q1 Earnings: Wall Street's Insights on Key Metrics
Get a deeper insight into the potential performance of Agilent (A) for the quarter ended January 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Bloomberg's 2026 Watch List Flags 5 Ideal 'Safer' February Dividend Buys
Bloomberg's 2026 Dividend Focus list highlights 16 'safer' stocks with free cash flow yields exceeding dividend yields, signaling strong dividend sustainability. Top projected net gains for 2026 include PT Telekom at 70.36%, with average net gain estimates of 28.13% across the top ten dividend-focused stocks. Five 'IDEAL' stocks—Continental, Aviva, PT Telekom, Danske Bank, and Western Midstream—offer dividends from $1,000 invested that exceed their single share price.
Active Managers Add 25% to Short-Term Bond Returns
Investors seeking protection from geopolitical volatility and stubborn inflation in 2026 may find opportunity in short-term bonds, where active management has historically delivered returns 25% higher than passive strategies, according to Vontobel Asset Management. Research going back to the 1990s shows investors in short-term, high-quality corporate bonds typically earn total returns of 1.
Agilent Technologies, Inc. (A) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Agilent Technologies, Inc. (A) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
